The estimated Net Worth of Hanlin Gao is at least $23.5 Milion dollars as of 3 September 2024. Hanlin Gao owns over 1,503 units of Fulgent Genetics Inc stock worth over $20,076,490 and over the last 9 years Hanlin sold FLGT stock worth over $3,381,275.
Sign up
Hanlin Gao FLGT stock SEC Form 4 insiders trading
Hanlin has made over 16 trades of the Fulgent Genetics Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Hanlin sold 1,503 units of FLGT stock worth $33,006 on 3 September 2024.
The largest trade Hanlin's ever made was selling 2,565,789 units of Fulgent Genetics Inc stock on 13 May 2016 worth over $3,001,973. On average, Hanlin trades about 55,991 units every 66 days since 2016. As of 3 September 2024 Hanlin still owns at least 923,057 units of Fulgent Genetics Inc stock.
You can see the complete history of Hanlin Gao stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Hanlin Gao's mailing address?
Hanlin's mailing address filed with the SEC is 4978 Santa Anita Ave Suite 205, Temple City, CA 91780, USA.
Insiders trading at Fulgent Genetics Inc
Over the last 8 years, insiders at Fulgent Genetics Inc have traded over $32,817,108 worth of Fulgent Genetics Inc stock and bought 1,136,382 units worth $9,558,758 . The most active insiders traders include Hanlin Gao, Ming Hsieh oraz Paul Kim. On average, Fulgent Genetics Inc executives and independent directors trade stock every 28 days with the average trade being worth of $848,250. The most recent stock trade was executed by Paul Kim on 3 September 2024, trading 1,674 units of FLGT stock currently worth $36,761.
What does Fulgent Genetics Inc do?
mission developing flexible and affordable genetic testing that improves the everyday lives of those around us. founded in 2011, fulgent began with two simple ideas; flexibility and affordability. today, we strive to create the most effective and wide ranging tests on the market. all of this is done in the pursuit of bettering the everyday lives of our customers. we shine brightest when meaningful relationships, passion, and purpose come together. why fulgent? we are committed to working side-by-side with every one of our clients. this is essential to a strong and successful relationship and is our core way of doing business. we have collaborated with some of the top clinicians in our field who have assisted us in creating our panels, report formatting, and improvements to our website. our approach has always been simple: provide testing based on the specific needs of clinicians and their patients. customer support our support philosophy has always been simple: answer our client's ques
What does Fulgent Genetics Inc's logo look like?
Complete history of Hanlin Gao stock trades at Fulgent Genetics Inc
Fulgent Genetics Inc executives and stock owners
Fulgent Genetics Inc executives and other stock owners filed with the SEC include:
-
Paul Kim,
Chief Financial Officer -
Han Lin Gao,
Chief Scientific Officer, Laboratory Director -
Paul Kim,
Chief Financial Officer -
Ming Hsieh,
Chairman, CEO & Pres -
Ming Hsieh,
Chairman of the Board, President, Chief Executive Officer -
Jian Xie,
Chief Operating Officer -
Dr. Han Lin Gao FACMG, M.D., Ph.D., D.A.B.M.G., F.A.C.M.G.,
Chief Scientific Officer & Laboratory Director -
Linda Marsh,
Independent Director -
John Bolger,
Independent Director -
Yun Yen,
Independent Director -
Nicole Borsje,
IR Contact Officer -
Dr. Lawrence M. Weiss M.D.,
Chief Medical Officer -
Brandon Perthuis,
Chief Commercial Officer -
James Mulay,
Director -
Long Usa, Inc. Xi,
10% owner -
Genetics, Inc. Fulgent,
Director -
Michael Nohaile,
-
Regina E Groves,
-
Jian Xie,
President and COO -
Ming Ming Hsieh Trust Hsieh,
Chief Executive Officer -
Leonard E Post,
Director